6 Cannabis Stocks To Surge on California’s $4 Billion Rec Market

Stocks move in cycles and right now there is a clear cycle emerging in the cannabis sector.

This cycle is simple to understand and easy to follow,  but incredibly powerful.

Groundbreaking cannabis legislation hits the wire and a group of cannabis stocks soar.

This cycle was on display again last week on the most important day in the history of the cannabis industry.

On January 1, California legalized cannabis, giving birth to a $4 billion industry virtually overnight.

The legislative breakthrough sent US cannabis stocks are surging. For example, Potnetwork Holdings (OTC: POTN), a US-based cannabis company that specializes in cannabinoid infused consumer products, is up more than 300% in the last four weeks.

As you can see, early investors were rewarded handsomely for buying ahead of the curve.

If you missed out on the big rally, don’t worry. It’s not too late to cash in on California.

Cannabis Sales Expected to Explode to $4 Billion in Three Years

California is already the largest cannabis market in the world. This west coast giant’s legal and illegal cannabis market did around $8 billion in sales in 2016, with 75% of that total coming from illegal sales.

Legalizing recreational is expected to quickly chip into illegal sales and grow into a $4 billion annual market within a few years, from basically $0 today.

That is a potential revenue and profit windfall for cannabis companies ready to capitalize.

This should be a strong tailwind for US cannabis stocks for the next two years as the industry continues to expand.

Cannabis Stocks are Getting Billions in Free Advertising

California’s recreational cannabis industry has gone viral. Cannabis has been one of the top trending stories in 2018. That has been great for the cannabis sector because it is attracting a whole new class of potential investors.

That’s the biggest reason billions in new capital flowed into cannabis stocks in the first few weeks of the year. Investors that have never been willing to give this sector a chance are getting interested in cannabis stocks as the industry gains credibility.

Those two powerful reasons are why I am bullish on US cannabis stocks right now.

This is the perfect time to invest.

The sector just emerged out of a nasty bear market and has major momentum. 

This looks like a long-term bottom to me and the beginning of a new bull market in US cannabis stocks, all being triggered by California.

Below is a list of six US cannabis stocks that are already cashing in on California’s new recreational program.

1. Kush Bottles (KSHB)

Headquartered: Santa Clara, CA
Market Cap: $336M
About: Kush Bottles sells packaging products to the US cannabis industry.

2. Terra Tech (TRTC)

Headquartered: Irvine, CA
Market Cap: $272M
About: Terra Tech owns a line of dispensaries in California and Nevada under the brand name Blum.

3. Innovative Industries Properties

Headquartered: San Diego, CA
Market Cap: $117M
About: Innovative Property Resources leases cannabis greenhouses to cultivation companies looking to ramp production.

4. Grow Generation (GRWG)

Headquartered: Denver, CO
Market Cap: $114M
About: Growgeneration operates more than a dozen retail stores in Colorado and California that sell hydroponic and organic gardening supplies to cannabis growers.

5. Americann (ACAN)

Headquartered: Denver, CO
Market Cap: $70M
About: Americann (ACAN) is shooting to become one of the largest cannabis growers on the East Coast with its ambitious plans to build a 1 million square foot cannabis greenhouse in Massachusetts.

6. Solistek (SLTK)

Headquartered: Carson, CA
Market Cap: $68M
About: Solistek sells specialty lighting equipment to the cannabis industry.

 


RISKS TO CONSIDER: Cannabis is still illegal on the federal level in the US. That makes US cannabis stocks vulnerable to legal risk and uncertainty.

ACTION TO TAKE:  Look for California’s new recreational market to drive sales and lift shares into all-time highs by the end of the year.

 

Jeff Sessions Cole Memo Update – Cannabis Stock Trades

Greetings Friends,
Cannabis stocks took a hit today after US Attorney General Jeff Sessions rescinded the Cole Memo – legislation that basically makes it illegal for the Feds to go after state cannabis programs.
In the short run cannabis stocks are down. But in the long run I don’t think this will have any impact on the cannabis industry or the potential of cannabis stocks.
Here’s a video with some more thoughts.

Forget Black Friday – It’s Green Friday!

Forget Black Friday, it’s Green Friday!

Take a 2-Week Free Trial to Cannabis Stock Trades.

That’s right, two weeks to access our model portfolio which is up over 50% year-to-date.

You’ll also receive exclusive analysis and investment ideas, trade alerts for our model portfolio, and the ability to chat with our analyst, Michael Vodicka, and hundreds of other traders and investors excited about the cannabis sector!

Start your trial to learn about some of the stellar performers in our portfolio, including:

– A little-known Australian startup with an exclusive permit to grow and sell medical cannabis. Our members scored a 330% gain after our buy alert on July 31.

– An early global-leader in Canada ready to pounce on the country’s recreational market in the summer of 2018. Shares are up 145% since our buy signal went out.

If you decide that a CST membership isn’t a good fit for you, just contact us to cancel within your trial period. But if you love it (which we bet you will), you’ll continue as a member for only $29.99 – cancel anytime.

Enjoy this awesome deal,

Michael Vodicka
Cannabis Stock Trades

3 Reasons Why I Like IIPR, “The Cannabis Landlord”

Innovative Industrial Properties, Inc. IIPR is fairly new to the cannabis industry, only hitting the NYSE in November of 2016.

There are 3 big reasons why this stock is on my radar and why you may want to look at it too.

Disclosure: On of Jan 24, 2017, Michael Vodicka owns/owned shares of IIPR.

The information contained in this video is for informational and educational purposes only. The trading ideas and stock selections represented on the Cannabis Stock Trades website are not tailored to your individual investment needs. Readers and members are advised to consult with their financial advisor before entering into any trade. Cannabis stocks carry a certain level of risk and we accept no responsibility for any potential losses. All trades, patterns, charts, systems, etc. discussed are for illustrative purposes only and not to be construed as specific advisory recommendations. All ideas and material presented are entirely those of the author and do not necessarily reflect those of the publisher.

Cannabis Stocks Earnings Calendar – March 2017

Please remember that companies may change their announcement dates. Please do your research prior to making any trading decision.

CODI – Compass Diversified Holdings
ZDPY – Zoned Properties, Inc.
CARA – Cara Therapeutics, Inc.
ZYNE – Zynerba Therapeutics
MCIG – mCig, Inc.
GWPH – GW Pharmaceuticals
TRTC – Terra Tech Corp.
CANN – General Cannabis Corp.

Big Potential For This Pure-Play Cannabis Dispensary Stock

 

This cannabis company had a 731% revenue growth in 2016, with OTC shares up 395% in the last 12 month. I think this is one of the most unique, pure-play dispensary stocks out there right now.

Sign up for my free weekly newsletter!

Disclosure: I owned shares of KAYS on Jan 18, 2017, the day that this video was published. I may or may not still hold this security.

The information contained in this video is for informational and educational purposes only. The trading ideas and stock selections represented on the Cannabis Stock Trades website are not tailored to your individual investment needs. Readers and members are advised to consult with their financial advisor before entering into any trade. Cannabis stocks carry a certain level of risk and we accept no responsibility for any potential losses. All trades, patterns, charts, systems, etc. discussed are for illustrative purposes only and not to be construed as specific advisory recommendations. All ideas and material presented are entirely those of the author and do not necessarily reflect those of the publisher.

My #1 Cannabis Stock For 2017

Sign Up For My Free Weekly Newsletter

Disclosure: On Jan 4, 2017, I own shares of CGC. I may or may not still hold this security.

he information contained in this video is for informational and educational purposes only. The trading ideas and stock selections represented on the Cannabis Stock Trades website are not tailored to your individual investment needs. Readers and members are advised to consult with their financial advisor before entering into any trade. Cannabis stocks carry a certain level of risk and we accept no responsibility for any potential losses. All trades, patterns, charts, systems, etc. discussed are for illustrative purposes only and not to be construed as specific advisory recommendations. All ideas and material presented are entirely those of the author and do not necessarily reflect those of the publisher.

4 Cannabis Stocks With The Best Chance To Be The Next Starbucks

Michael Vodicka
Editor, Cannabis Stock Trades

Back in 1991, very few people had heard of a company called Starbucks.

After all, what kind of fool would pay more than $2 for a cup of coffee? Particularly when you could brew a cup at home.

Today, Starbucks is a billion-dollar global leader and one of the most recognized consumer brands in the world. Early investors have been rewarded with life-changing gains.

Shares are up almost 17,000% in the last 25 years. Investing $10,000 at the IPO in 1991 would be worth $1.7 million today. $25,000 would have grown into $4.4 million. Take a look at the big gains below.

8102

This is my model for investing in cannabis stocks.

I’m looking for the next Starbucks. I call this big game hunting. I’m looking for a White Whale.

After this week, I’m convinced I know exactly where it’s going to come from.

Canada Is On The Verge Of Its Biggest Cannabis Breakthrough Ever

Countries across the globe are duking it out for early leadership in the high-growth cannabis industry.

That’s no surprise. Billions in annual tax revenue are at stake.

From the field, no other country comes close to dominating like Canada.

Medical marijuana has been legal in the country since 2001. This still hasn’t happened in the U.S. 15 years later.

In July of 2013, Canada implemented the MMPR (Medical Marijuana Purposes Regulation), a dedicated federal agency to regulate the production and distribution of medical marijuana.
These events have given birth to a thriving industry servicing hundreds of thousands of patients and generating tens of millions in tax revenue every year.

Today, Canada’s cannabis industry is on the verge of its biggest breakthrough ever.

This week the Task Force on Cannabis Legalization and Regulation presented a highly anticipated report to the Ministers of Health, Justice and Public safety on how the federal government should move forward with the legalization of recreational cannabis in the country.

The report makes more than 80 recommendations. That includes setting 18 as a legal age to purchase, restricting advertising similar to tobacco products, establishing uniform packaging and labels and setting maximum THC levels.

Canada could vote of legalizing recreational cannabis as early as this spring. This report creates a road map for the industry. I believe that increases the probability of an approval.

That would make Canada the first country in the North America to legalize recreational.

That would have huge implications for Canada’s fast growing cannabis industry.

A new study from consulting firm Deloitte projects that annual sales in Canada could immediately be around $5 billion, equal to hard alcohol sales and as much as $9 billion, equal to wine sales.

More important, a yes vote would create a legal and operating platform for Canada’s cannabis companies to expand into international markets and grow into global leaders.

This is critical knowledge for cannabis investors to understand.

There are more than 250 stocks in the global cannabis market.

Every week, new companies enter the industry.

Trying to pick winners and losers from that list is like trying to find a needle in a haystack.

Instead of endlessly sifting through hundreds of worthless penny stocks in the U.S., where cannabis is still illegal in all forms, “big game hunters” searching for the Starbucks of cannabis should focus on Canada.

This is why I own a number of these stocks (disclosed below).

It’s the reason I have been buying these stocks for my wealth management clients at the Vodicka Group, Inc.

It’s the reason these stocks will be the core of the model portfolio we are getting ready to launch through Cannabis Stock Trades Premium.

For the time being, here is a list of the four largest Canadian medical marijuana companies.

Top 4 Canadian Medical Marijuana Stocks

Company Ticker Market Cap
Canopy Growth Corp CGC $1.2 Billion
Aurora Cannabis ACB $590 Million
Aphria APH $482 Million
Organigram OGI $191 Million

Please keep these stocks on your radar. I believe they are in position to grow into global leaders. That could translate into massive gains for early shareholders.

Disclosure: Michael Vodicka owns shares of CGC, APH, and OGI.